<DOC>
	<DOCNO>NCT00429936</DOCNO>
	<brief_summary>The purpose phase II study determine efficacy fenretinide treatment geographic atrophy ( GA ) subject dry form age-related macular degeneration ( AMD ) .</brief_summary>
	<brief_title>Study Fenretinide Treatment Geographic Atrophy Associated With Dry Age-Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Geographic Atrophy</mesh_term>
	<criteria>male female , 50 89 year age must GA AMD one eye GA due disease AMD ( eg , druginduced )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Dry Age Related Macular Degeneration</keyword>
	<keyword>Geographic Atrophy</keyword>
</DOC>